CAMX

710

-1.18%↓

VITR

144.5

-0.48%↓

ARJOB

34.22

-2.06%↓

MSON.B

7.9

+1.28%↑

ORX

20.7

-3.94%↓

CAMX

710

-1.18%↓

VITR

144.5

-0.48%↓

ARJOB

34.22

-2.06%↓

MSON.B

7.9

+1.28%↑

ORX

20.7

-3.94%↓

CAMX

710

-1.18%↓

VITR

144.5

-0.48%↓

ARJOB

34.22

-2.06%↓

MSON.B

7.9

+1.28%↑

ORX

20.7

-3.94%↓

CAMX

710

-1.18%↓

VITR

144.5

-0.48%↓

ARJOB

34.22

-2.06%↓

MSON.B

7.9

+1.28%↑

ORX

20.7

-3.94%↓

CAMX

710

-1.18%↓

VITR

144.5

-0.48%↓

ARJOB

34.22

-2.06%↓

MSON.B

7.9

+1.28%↑

ORX

20.7

-3.94%↓

Search

Elekta AB

Open

49.28 -0.65

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

48.1

Max

49.78

Belangrijke statistieken

By Trading Economics

Inkomsten

-738M

-307M

Verkoop

461M

5.2B

K/W

Sectorgemiddelde

76.968

38.156

EPS

1.11

Dividendrendement

5.04

Winstmarge

-5.954

Werknemers

4,536

EBITDA

-725M

124M

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

5.04%

2.50%

Volgende Winsten

27 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-695M

18B

Vorige openingsprijs

49.93

Vorige sluitingsprijs

49.28

Elekta AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 jul 2025, 23:57 UTC

Acquisities, Fusies, Overnames

EQT: To Spend Y407.82B for Tender Offer

29 jul 2025, 23:56 UTC

Acquisities, Fusies, Overnames

EQT: Tender Offer Price Is Y5,700 a Share

29 jul 2025, 23:54 UTC

Acquisities, Fusies, Overnames

EQT To Start Tender Offer for Fujitec

29 jul 2025, 23:50 UTC

Marktinformatie

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 jul 2025, 23:36 UTC

Marktinformatie

Gold Steady Ahead of FOMC Decision -- Market Talk

29 jul 2025, 22:57 UTC

Marktinformatie

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 jul 2025, 22:50 UTC

Marktinformatie

Mondelez Warns of Price Increases in North America -- Market Talk

29 jul 2025, 22:44 UTC

Acquisities, Fusies, Overnames

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 jul 2025, 22:41 UTC

Acquisities, Fusies, Overnames

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 jul 2025, 22:41 UTC

Acquisities, Fusies, Overnames

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 jul 2025, 22:35 UTC

Winsten

IGO Maintains Nova Life of Mine Production Guidance

29 jul 2025, 22:35 UTC

Winsten

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 jul 2025, 22:35 UTC

Winsten

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 jul 2025, 22:34 UTC

Winsten

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 jul 2025, 22:34 UTC

Winsten

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 jul 2025, 22:34 UTC

Marktinformatie
Winsten

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 jul 2025, 22:33 UTC

Winsten

IGO Had A$279.7 Million of Cash at End-June

29 jul 2025, 22:33 UTC

Winsten

IGO 4Q Underlying Free Cash A$2.4 Million

29 jul 2025, 22:33 UTC

Winsten

IGO FY Sales Revenue A$512.5 Million

29 jul 2025, 22:33 UTC

Winsten

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 jul 2025, 22:32 UTC

Winsten

IGO FY Nickel Production 17,173 Tons

29 jul 2025, 22:32 UTC

Winsten

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 jul 2025, 22:32 UTC

Winsten

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 jul 2025, 22:31 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

29 jul 2025, 22:31 UTC

Marktinformatie
Winsten

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 jul 2025, 22:31 UTC

Winsten

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 jul 2025, 22:31 UTC

Winsten

IGO FY Spodumene Production 1.48 Million Tons

29 jul 2025, 22:30 UTC

Winsten

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 jul 2025, 22:30 UTC

Winsten

IGO 4Q Underlying Ebitda A$62 Million

29 jul 2025, 22:22 UTC

Winsten

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Peer Vergelijking

Prijswijziging

Elekta AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.